{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:48:54Z","timestamp":1773236934929,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1008913828105","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T17:46:35Z","timestamp":1040579195000},"page":"231-238","source":"Crossref","is-referenced-by-count":144,"title":["Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer"],"prefix":"10.1007","volume":"11","author":[{"given":"Diana C.","family":"Farrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilie D.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wong-Ho","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey A.","family":"Risch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Hansten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet B.","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Rotterdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibul","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Brian","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Dubrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Fraumeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"254059_CR1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","volume":"265","author":"WJ Blot","year":"1991","unstructured":"Blot WJ, Devesa SS, Kneller RW, Fraumeni JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA\n265: 1287\u20131289.","journal-title":"JAMA"},{"key":"254059_CR2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/jnci\/89.17.1277","volume":"89","author":"MD Gammon","year":"1997","unstructured":"Gammon MD, Schoenberg JB, Ahsan H, et al. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst\n89: 1277\u20131284.","journal-title":"J Natl Cancer Inst"},{"key":"254059_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jama.1995.03530060048032","volume":"274","author":"W-H Chow","year":"1995","unstructured":"Chow W-H, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr (1995) The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA\n274: 474\u2013477.","journal-title":"JAMA"},{"key":"254059_CR4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symp-tomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med\n340: 825\u2013831.","journal-title":"N Engl J Med"},{"key":"254059_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jnci\/90.2.150","volume":"90","author":"W-H Chow","year":"1998","unstructured":"Chow W-H, Blot WJ, Vaughan TL, et al. (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst\n90: 150\u2013155.","journal-title":"J Natl Cancer Inst"},{"key":"254059_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00053153","volume":"4","author":"GC Kabat","year":"1993","unstructured":"Kabat GC, Ng SKC, Wynder EL (1993) Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control\n4: 123\u2013132.","journal-title":"Cancer Causes Control"},{"key":"254059_CR7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01804984","volume":"5","author":"LM Brown","year":"1994","unstructured":"Brown LM, Silverman DT, Pottern LM, et al. (1994) Adenocar-cinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco,and socioeconomic factors. Cancer Causes Control\n5: 333\u2013340.","journal-title":"Cancer Causes Control"},{"key":"254059_CR8","first-page":"85","volume":"4","author":"TL Vaughan","year":"1995","unstructured":"Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcino-ma. Cancer Epidemiol Biomarkers Prev\n4: 85\u201392.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"254059_CR9","first-page":"749","volume":"7","author":"TL Vaughan","year":"1998","unstructured":"Vaughan TL, Farrow DC, Hansten PD, et al. (1998) Risk of esophageal and gastric adenocarcinoma in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomark-ers Prev\n7: 749\u2013756.","journal-title":"Cancer Epidemiol Biomark-ers Prev"},{"key":"254059_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF01831386","volume":"5","author":"HH Wang","year":"1994","unstructured":"Wang HH, Hsieh CC, Antonioli DA (1994) Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). Cancer Causes Control\n5: 573\u2013578.","journal-title":"Cancer Causes Control"},{"key":"254059_CR11","doi-asserted-by":"crossref","unstructured":"Anonymous (1998) Top 200 drugs of 1997. Pharm Times,April.","DOI":"10.3928\/0147-7447-19980201-16"},{"key":"254059_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(79)92757-0","volume":"1","author":"JB Elder","year":"1979","unstructured":"Elder JB, Ganguli PC, Gillespie IE (1979) Cimetidine and gastric cancer. Lancet\n1: 1005\u20131006.","journal-title":"Lancet"},{"key":"254059_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3835(80)90139-1","volume":"9","author":"AB Foster","year":"1980","unstructured":"Foster AB, Jarman M, Manson D, Schulten HR (1980) Structure and reactivity of nitrosocimetidine. Cancer Lett\n9: 47\u201352.","journal-title":"Cancer Lett"},{"key":"254059_CR14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/gut.30.11.1558","volume":"30","author":"H Moller","year":"1989","unstructured":"Moller H, Lindvig K, Klefter R, Mosbech J, Moller Jensen O (1989) Cancer occurrence in a cohort of patients treated with cimetidine. Gut\n30: 1558\u20131562.","journal-title":"Gut"},{"key":"254059_CR15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/gut.33.9.1166","volume":"33","author":"H Moller","year":"1977","unstructured":"Moller H, Nissen A, Mosbech J (1992) Use of cimetidine and other peptic ulcer drugs in Denmark 1977\u20131990 with analysis of the risk of gastric cancer among cimetidine users. Gut\n33: 1166\u20131169.","journal-title":"Gut"},{"key":"254059_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0140-6736(90)91888-H","volume":"336","author":"C LaVecchia","year":"1990","unstructured":"LaVecchia C, Negri E, Davanzo B, Franceschi S (1990) Histamine-2\u2013receptor antagonists and gastric cancer risk. Lancet\n336: 355\u2013357.","journal-title":"Lancet"},{"key":"254059_CR17","first-page":"177","volume":"8","author":"C LaVecchia","year":"1992","unstructured":"LaVecchia C, Negri E, Franceschi S, D'Avanzo B (1992) Hista-mine-2\u2013receptor antagonists and gastric cancer: update and note on latency and covariates. Nutrition\n8: 177\u2013181.","journal-title":"Nutrition"},{"key":"254059_CR18","first-page":"13","volume":"78","author":"DG Colin-Jones","year":"1991","unstructured":"Colin-Jones DG, Langman MJS, Lawson DH, Logan RFA, Paterson KR, Vessey MP (1991) Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus. Q J Med\n78: 13\u201319.","journal-title":"Q J Med"},{"key":"254059_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00001648-199607000-00016","volume":"7","author":"AG Johnson","year":"1996","unstructured":"Johnson AG, Jick SS, Perera DR, Jick H (1996) Histamine-2 receptor antagonists and gastric cancer. Epidemiology\n7: 434\u2013436.","journal-title":"Epidemiology"},{"key":"254059_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00001648-199005000-00012","volume":"1","author":"MC Schumacher","year":"1990","unstructured":"Schumacher MC, Jick SS, Jick H, Feld D (1990) Cimetidine use and gastric cancer. Epidemiology\n1: 251\u2013254.","journal-title":"Epidemiology"},{"key":"254059_CR21","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, et al. (1998). Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev\n7: 97\u2013102.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008913828105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1008913828105\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008913828105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:13:49Z","timestamp":1750961629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1008913828105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["254059"],"URL":"https:\/\/doi.org\/10.1023\/a:1008913828105","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}